Optimum Quantvest Corp - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.

Quarter-by-quarter ownership
Optimum Quantvest Corp ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2020$3,523,000
+6.8%
89,9620.0%6.80%
+1.1%
Q2 2020$3,300,000
+196.2%
89,962
+86.0%
6.73%
+176.6%
Q1 2020$1,114,000
-21.3%
48,3620.0%2.43%
-13.6%
Q4 2019$1,416,000
+9.6%
48,3620.0%2.82%
+256.1%
Q3 2019$1,292,000
+4.5%
48,3620.0%0.79%
+2.2%
Q2 2019$1,236,00048,3620.77%
Other shareholders
VANECK VECTORS ETF TR shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 738,500$19,873,03580.92%
New Harbor Financial Group, LLC 1,680,752$45,229,03314.96%
TORQ CAPITAL MANAGEMENT (HK) Ltd 139,000$3,740,4909.95%
Vanderbilt University 1,360,540$36,612,1319.45%
Eschler Asset Management LLP 300,000$8,073,0009.42%
New Harbor Financial Group, LLC 1,027,300$27,644,6439.15%
Guild Investment Management, Inc. 139,333$3,749,4546.28%
Monaco Asset Management SAM 750,000$20,182,5005.98%
STRATEGIC INVESTMENT MANAGEMENT, LLC 132,460$3,867,8324.74%
PCG Wealth Advisors, LLC 264,614$7,120,7824.67%
View complete list of VANECK VECTORS ETF TR shareholders